| 000 | 01148 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250514153705.0 | ||
| 264 | 0 | _c19981101 | |
| 008 | 199811s 0 0 eng d | ||
| 022 | _a0002-9149 | ||
| 024 | 7 |
_a10.1016/0002-9149(62)90104-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKIRKENDALL, W M | |
| 245 | 0 | 0 |
_aPharmacodynamics and clinical use of guanethidine, bretylium and methyldopa. _h[electronic resource] |
| 260 |
_bThe American journal of cardiology _cJan 1962 |
||
| 300 |
_a107-15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAmidines _xtherapy |
| 650 | 0 | 4 |
_aAntitubercular Agents _xtherapy |
| 650 | 0 | 4 | _aBretylium Compounds |
| 650 | 0 | 4 |
_aDihydroxyphenylalanine _xanalogs & derivatives |
| 650 | 0 | 4 | _aGuanethidine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xtherapy |
| 650 | 0 | 4 |
_aLyases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMethyldopa |
| 650 | 0 | 4 |
_aSympatholytics _xtherapy |
| 700 | 1 | _aWILSON, W R | |
| 773 | 0 |
_tThe American journal of cardiology _gvol. 9 _gp. 107-15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0002-9149(62)90104-2 _zAvailable from publisher's website |
| 999 |
_c14217984 _d14217984 |
||